- Home
- YMT vs CERS Comparison
YMT vs CERS Comparison
Compare YMT & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMT
- CERS
- Stock Information
- Founded
- YMT 2011
- CERS 1991
- Country
- YMT China
- CERS United States
- Employees
- YMT N/A
- CERS N/A
- Industry
- YMT EDP Services
- CERS EDP Services
- Sector
- YMT Technology
- CERS Technology
- Exchange
- YMT Nasdaq
- CERS Nasdaq
- Market Cap
- YMT 263.1M
- CERS 276.0M
- IPO Year
- YMT 2025
- CERS 1997
- Fundamental
- Price
- YMT $1.79
- CERS $1.60
- Analyst Decision
- YMT
- CERS Strong Buy
- Analyst Count
- YMT 0
- CERS 2
- Target Price
- YMT N/A
- CERS $3.50
- AVG Volume (30 Days)
- YMT 84.5K
- CERS 1.6M
- Earning Date
- YMT 01-01-0001
- CERS 10-29-2025
- Dividend Yield
- YMT N/A
- CERS N/A
- EPS Growth
- YMT N/A
- CERS N/A
- EPS
- YMT N/A
- CERS N/A
- Revenue
- YMT $21,547,440.00
- CERS $192,510,000.00
- Revenue This Year
- YMT N/A
- CERS $22.02
- Revenue Next Year
- YMT N/A
- CERS $9.32
- P/E Ratio
- YMT N/A
- CERS N/A
- Revenue Growth
- YMT 19.68
- CERS 13.25
- 52 Week Low
- YMT $1.70
- CERS $1.12
- 52 Week High
- YMT $6.05
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- YMT N/A
- CERS 60.70
- Support Level
- YMT N/A
- CERS $1.46
- Resistance Level
- YMT N/A
- CERS $1.67
- Average True Range (ATR)
- YMT 0.00
- CERS 0.10
- MACD
- YMT 0.00
- CERS 0.01
- Stochastic Oscillator
- YMT 0.00
- CERS 81.40
About YMT Yimutian Inc. American Depositary Shares
Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.